Download the exclusive Guide and read about: What are the benefits cell line development is bringing to biopharmaceutical developers? What technological advances are helping drive efficiencies in cell line development? How is this process underpinning drug development and why is the market growing? In what ways is cell line development… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Dr Friso Postma,… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Dr Friso Postma,… Read More
The Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, a neuroscience research institute based in Houston, has advanced its research capabilities with the implementation of an automation platform for human cellular model generation, maintenance, and characterisation, in collaboration with Automata Technologies. As… Read More
At this year’s annual European Society of Cardiology conference (ESC Congress 2024), which took place from 30 August – 2 September, AstraZeneca presented research that spans 38 abstracts, focusing on unmet need in heart failure (HF) and transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), and other chronic diseases. Data highlights… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the release of clinical study results that led some media titles to ask… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the release of clinical study results that led some media titles… Read More
Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format. With the release of clinical… Read More
Recently, the Novo Nordisk Foundation updated its strategy to include regenerative medicine. While regenerative medicine is not new to the Foundation, it is now an explicit part of the company’s strategy. DDW’s Megan Thomas caught up with Martin Ridderstråle, Senior Vice President and Head of Medical Science at the… Read More
The Phase II NANOBRAINMETS trial of AGuIX has been validated by the Data Safety and Monitoring Board (DSMB) following a futility analysis scheduled after the enrolment and follow-up of 50% of patients in the study. The trial is being run by NH TherAguix, a biotechnology company developing… Read More
Brain disease specialist Aelis Farma has announced results from the clinical Phase IIB trial study of AEF0117, evaluating its efficacy and safety in treatment-seeking participants with moderate to severe Cannabis Use Disorder (CUD) that used cannabis ≥5 days/week at baseline. In this study population, 82% of… Read More
Regina Fritsche Danielson, Senior Vice President and Global Head, Research and Early Development, CVRM, AstraZeneca, shares insight with DDW’s Megan Thomas on the first precision medicine to treat APOL1-mediated kidney disease (AKMD). MT: Can you provide an overview of the key findings from the study on APOL1-mediated kidney… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the launch of an international clinical trial investigating BioNTech’s mRNA lung cancer vaccine… Read More
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the launch of an international clinical trial investigating BioNTech’s mRNA lung… Read More
Every week, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates in the DDW Highlights podcast. It is now also available in a concise vodcast format. With the launch of an… Read More
A lung cancer patient at University College London Hospitals (UCLH) is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells. It is the first time this immunotherapy made by BioNTech will be studied in a clinical… Read More
